A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...

A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in ...

A 2024 nationwide survey of French ICUs reveals critical gaps in managing invasive candidiasis, including underutilization of ...

Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...

Discover a Phase 3 trial that evaluated stapokibart as an additional therapy for adults with moderate-to-severe seasonal ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

A new review examines the effectiveness of surgical treatments for severe osteoarthritis, highlighting the dominance of total ...

In people living with HIV, gut microbiome differences linked to antiretroviral therapy and weight gain are small compared to ...

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to ...

Discover a study about an AI model named PLAN-B-DF that has been developed to improve the prediction of hepatocellular ...

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma ...

New research suggests that regular physical activity can improve survival rates in stage III colon cancer, reducing the ...